Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 802 results for "ipf"

Idiopathic pulmonary fibrosis cases linked with asbestos exposure

Asbestos May Trigger Pulmonary Fibrosis

MUNICH — Some cases of idiopathic pulmonary fibrosis (IPF) may be due to environmental or occupational exposure to asbestos, according to a new analysis of mortality data in England and Wales. This suggests that patients with known asbestos ... American Journal of Public Health, 14 hours ago

29 images for ipf, 1 week ago
MyScience, 3 days ago
Pharma Letter, 5 days ago
ABC News 4 Charleston, 6 days ago
Sys-Con Media, 6 days ago
Emirates Week, 2 weeks ago
XinMsn, 1 week ago
BusinessWeek, 1 week ago
American Banking News, 1 week ago
GlobeNewswire, 2 weeks ago
World Connector Net

Positive new data on Boehringer's nintedanib in IPF patients

A pre-specified subgroup analysis from the two replicate Phase III INPULSI trials, presented today at the European Respiratory Society International Congress (ERS), showed that German family-owned pharma major Boehringer Ingelheim's nintedanib ...
 Pharma Letter5 days ago Nintedanib* slowed disease progression in IPF independent of patients lung function impairment at baseline  Business Wire1 week ago Nintedanib Slowed Disease Progression in IPF Independent of Patients Lung Function Impairment at Baseline  Emirates Week6 days ago Data shows that nintedanib slowed lung function decline in patients independent of their lung function impairment at baseline  Medical News Today4 days ago

Ontarians with rare lung disease finally given the chance to breathe

IPF patients in other provinces hope publicly-funded access to first and only treatment isn't far behind TORONTO, Sept. 3, 2014 /CNW/ - Ontarians affected by idiopathic pulmonary fibrosis (IPF) a rare, progressive and fatal lung disease have ...
 BusinessWeek1 week ago

Roche To Acquire InterMune, Promising IPF Drug

By Roche announced that it is acquiring Brisbane-based biotech firm InterMune for $8.3 billion. Under the terms of the agreement, Roche will acquire InterMune at $74 per share on a fully diluted basis. Roche will submit a tender offer no later ...
 Pharmaceutical Online2 weeks ago Roche and InterMune Reach Definitive Merger Agreement  4 Traders1 week ago Roche CEO Schwan took a hands-on approach negotiating $8.3B InterMune buyout  FierceBiotech1 week ago Roche Acquiring InterMune for $8.3 Billion  FDA News1 week ago

Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF)

Sorrento Therapeutics, Inc. (NASDAQ:SRNE) Intraday Stock Chart Today : Tuesday 26 August 2014 SAN DIEGO , Aug. 26, 2014 /PRNewswire/ --Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new ...
 ADVFN India2 weeks ago Sorrento receives funding to advance immunotherapy targeting WISP1 for treatment of IPF  News-Medical.Net2 weeks ago Sorrento secures NIH Grant to advance immunotherapy for IPF treatment  Pharmaceutical Business Review2 weeks ago SRNE: NIH Provides Funding for Sorrento's Immunotherapy Targeting Idiopathic Pulmonary Fibrosis  Yahoo! Finance1 week ago

Haldia Petro shutdown spells doom for downstream sector: IPF

shadow on the future of numerous downstream plastic units in West Bengal, the Indian Plastics Federation (IPF) said. The HPL shutdown led to the closure of nearly 150 such units, rendering thousands jobless, IPF said in a statement. The HPL plant was shut ...
 Business Standard1 month ago Indian Plastics Federation announces INDPLAS '15, sets sights on major international participation  Plastemart.com1 week ago HPL may reopen after Pujas  Times of India1 week ago HPL shutdown paves way for other petro majors to tap east  Business Standard India1 week ago

New Analysis of Phase III Trials Examines the Impact of Boehringer Ingelheim's IPF Therapy Nintedanib on Lung Function Decline Based on Patients' Baseline Severity

RIDGEFIELD, Conn., Sept. 9, 2014 /PRNewswire/ -- A pre-specified, pooled subgroup sensitivity analysis from the two identically designed Phase III INPULSIS trials, presented today at the European Respiratory Society International Congress (ERS) ...
 Financial Content6 days ago To Mark Pulmonary Fibrosis Awareness Month, Boehringer Ingelheim Announces Discovery Channel Documentary on Idiopathic Pulmonary Fibrosis  Bio-Medicine5 days ago Analysis of Phase III Trials Examines the Impact of Nintedanib on Lung Function Decline  Drugs.com4 hours ago Boehringer Ingelheim Corporation And Duke Clinical Research Institute Form Collaborative Partnership To Study The Natural History Of Idiopathic Pulmonary Fibrosis (IPF)  Fierce Biotech Research1 week ago
Emirates Week

InterMune's IPF drug shines at ERS Congress

Pharmafile attended the European Respiratory Society Annual Congress in Munich InterMune has posted positive data for its lung-scarring drug at this year's European Respiratory Society Annual Congress 2014 (ERS). Pharmafile was present to ...
 Pharmafocus5 days ago Boehringer Ingelheim to present comprehensive data supporting broad respiratory portfolio in COPD, asthma and IPF at ERS 2014  Scottrade2 weeks ago
SPi World News

MediciNova to Present Data on MN-001 (tipelukast) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) During the 18th International Colloquium on Lung and Airway Fibrosis (ICLAF)

LA JOLLA, Calif., Sept. 1, 2014 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market ( Nasdaq:MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), today announced that it will ...
 Crawford Financial Planning2 weeks ago MediciNova, Inc. To Present Data On MN-001 (Tipelukast) For The Treatment Of Idiopathic Pulmonary Fibrosis (IPF) During The  BioSpace1 week ago MEDICINOVA : to Present Data on MN-001 (tipelukast) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) During the 18th International Colloquium on Lung and Airway Fibrosis (ICLAF)  4 Traders2 weeks ago MediciNova Announces New NIDA Grant for MN-166 (ibudilast) in Opioid Dependence  Industrial Info Financials1 week ago

Investec Property Fund expands recently acquired Dihlabeng Mall in Bethlehem

When the (IPF) listed on the JSE in April 2011 the portfolio included only four retail properties worth R174 million. Today the Fund boasts 29 quality retail assets, including big box retail and motor dealerships, valued at R2,7 billion out of the ... days ago IPF: INVESTEC PROPERTY FUND LIMITED - Disclosure of acquisition and disposal of securities  JSE Securities Exchange3 weeks ago Dihlabeng Mall in Bethlehem gets 5000m 2extension  Biz Community1 hour ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less